Mishaela Ruth Rubin MD
Diabetes, Lipid Metabolism
Assistant Professor, Medicine, Columbia University College of Phys & Surg
Request Appointment
180 Fort Washington AvenueNew York, NY 10032
Overview of Dr. Rubin
Dr. Mishaela Rubin is an endocrinologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 22 years. Dr. Rubin accepts several types of health insurance, listed below. She is one of 149 doctors at New York-Presbyterian Hospital and one of 64 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Endocrinology. She has more than 100 publications and over 500 citings.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 1999 - 2002- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1995 - 1998
Columbia University Vagelos College of Physicians and SurgeonsClass of 1995
Certifications & Licensure
NJ State Medical License 1998 - 2027
NY State Medical License 1996 - 2026
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013, 2015-2017
Clinical Trials
- Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D Start of enrollment: 2010 May 01
- Therapy of the Skeletal Disease of Type 2 Diabetes With Denosumab Start of enrollment: 2018 Nov 07
- Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With Pyridoxamine Start of enrollment: 2018 Mar 01
Publications & Presentations
PubMed
- Palopegteriparatide for Adults with Chronic Hypoparathyroidism: Skeletal Dynamics Through 3 yr of the Phase 2 paTH Forward Trial.Mishaela R Rubin, Bart L Clarke, Lorenz C Hofbauer, Aliya Khan, Peter Schwarz
Journal of Bone and Mineral Research. 2026-02-04 - Patient-Reported Outcomes in Palopegteriparatide-Treated Adults with Hypoparathyroidism: PaTH Forward Trial Extension.Mishaela Rubin, Andrea Palermo, Tamara Vokes, Aliya A Khan, Peter Schwarz
The Journal of Clinical Endocrinology and Metabolism. 2025-12-09 - Early U.S. Real-World Treatment Patterns and Outcomes in Palopegteriparatide Treatment for Patients With Hypoparathyroidism.Timothy Graham, Dolores M Shoback, Lisa Abbott, Sara Lubitz, Gary Edelson
Endocrine Practice. 2025-12-01
Journal Articles
- Comparative Effect of rhPTH(1‐84) on Bone Mineral Density and Trabecular Bone Score in Hypoparathyroidism and Postmenopausal OsteoporosisMishaela R Rubin, Donald J McMahon, John P Bilezikian, Natalie E Cusano, Journal of Bone and Mineral Research
Press Mentions
MBX to Advance Hypoparathyroidism Drug to Phase III TrialSeptember 23rd, 2025- MBX Biosciences Announces Once-Weekly Canvuparatide Achieved Primary Endpoint in Phase 2 Trial with 63% Responder Rate at 12 Weeks; 79% Responder Rate at 6 Months in Open-Label ExtensionSeptember 22nd, 2025
- The Hypoparathyroidism Association Announces Patient Enrollment in First Prospective Hypoparathyroidism Natural History StudyMay 23rd, 2023
Grant Support
- Advancing Product Development for Hypoparathyroidism: A Prospective Natural History Study of the Clinical Outcomes and Regulation of Disordered Mineral MetabolismCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2026
- Advancing Product Development for Hypoparathyroidism: A Prospective Natural History Study of the Clinical Outcomes and Regulation of Disordered Mineral MetabolismCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2026
- Skeletal Health in Youth with Type 1 Diabetes and Gender DiversityCOLUMBIA UNIVERSITY HEALTH SCIENCES2019–2025
- Skeletal Health in Youth with Type 1 Diabetes and Gender DiversityCOLUMBIA UNIVERSITY HEALTH SCIENCES2019–2025
- The Skeletal Effects Of Reducing Inflammation In Type 2 Diabetes MellitusNational Institute Of Diabetes And Digestive And Kidney Diseases2010
Insurance Accepted
- BCBS Blue Card PPO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
Great West PPOMultiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
